Peers of Castle Biosciences Inc (CSTL)
Side-by-side comparison
Health Care · Health Care Providers & Services
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
-45.67x
As of Oct 14, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Oct 14, 2026 | -45.67x |
| Oct 13, 2026 | -45.21x |
| Oct 12, 2026 | -44.99x |
| Oct 9, 2026 | -48.05x |
| Oct 8, 2026 | -46.74x |
| Oct 7, 2026 | -45.43x |
| Oct 6, 2026 | -46.09x |
| Oct 5, 2026 | -52.17x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison